Evidence map›Paper›PMID 41007347›Full record

ReviewBiology2025

Stabilin-1 in Tumor-Associated Macrophages: A Potential Therapeutic Target in Cancer Immunotherapy.

Jampa Lhamo Gurung, Raju Lama Tamang, Lepakshe Madduri, Robert G Bennett, Edward N Harris, Paul W Denton, Benita McVicker

Abstract readReview
In one paragraph

Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jampa Lhamo GurungDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0006-5497-4187
Raju Lama TamangDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-3177-563X
Lepakshe MadduriDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Robert G BennettDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-0755-6103
Edward N HarrisDepartment of Biochemistry, University of Nebraska Lincoln, Lincoln, NE 68588, USA.ORCID 0000-0001-7045-1040
Paul W DentonDepartment of Biology, University of Nebraska Omaha, Omaha, NE 68182, USA.
Benita McVickerDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0001-7876-149X

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Heather Colleen Jensen-Smith · 2012 to 2026
$59.2M
Dissecting the Differential Impacts of Toll-like Receptor 9 Agonism on the Capacity of Human Natural Killer Cells to Mediate Target Cell KillingR15AI178516 · NIAID · UNIVERSITY OF NEBRASKA OMAHA · PI PAUL W. DENTON · 2023 to 2026
$743k
BLRD VA I01 BX005678Nebraska Research Initiative 31-3205-1235NIAID NIH HHS R15 AI178516NIGMS NIH HHS P20 GM103427
6 · The paper itself

Abstract

Stabilin-1 (STAB1) is a multifunctional scavenger receptor expressed by endothelial cells of the liver, spleen, lymph nodes, bone marrow and a subset of macrophages. STAB1 interacts with different ligands and modulates a wide range of functions including cell trafficking, endocytosis, homeostasis, angiogenesis, and tumor vascularization. The role of STAB1 in cancer progression and metastasis first became evident in

Indexed as

cancerCLEVER-1immunotherapymacrophagesstabilin-1tumor-associated macrophages

Identifiers

PMID41007347
PMCPMC12467216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.